- Case report
- Open Access
- Open Peer Review
This article has Open Peer Review reports available.
A case of lymphomatosis cerebri mimicking inflammatory diseases
- Takenobu Murakami1, 2Email author,
- Kenji Yoshida1,
- Mari Segawa1,
- Akioh Yoshihara1,
- Akihiko Hoshi1,
- Koichiro Nakamura3,
- Masahiro Ichikawa4,
- Osamu Suzuki5,
- Yuichi Yokoyama6,
- Yasuko Toyoshima6,
- Yoshihiro Sugiura1,
- Hiroshi Ito2,
- Kiyoshi Saito4,
- Yuko Hashimoto5,
- Akiyoshi Kakita6,
- Hitoshi Takahashi6 and
- Yoshikazu Ugawa1, 2
© The Author(s). 2016
Received: 15 September 2015
Accepted: 2 August 2016
Published: 8 August 2016
Lymphomatosis cerebri (LC) is a rare subtype of primary central nervous system malignant lymphoma. The typical features of this disease exhibited on magnetic resonance imaging (MRI) without contrast enhancement are similar to those observed with diffuse leukoencephalopathy, mimicking white matter disorders such as encephalitis. Clinical features and examination findings that are suggestive of inflammatory diseases may indeed confound the diagnosis of LC.
A 66-year-old woman with continuous fever over a two-month period developed left hemiparesis despite presenting in an alert state with normal cognitive function. Sampling tests showed autoantibodies in the serum and inflammatory changes in the cerebrospinal fluid. The results from an MRI demonstrated multiple non-enhanced brain lesions in the splenium of the corpus callosum and deep white matter. Single photon emission computed tomography revealed increases in blood flow in the basal ganglia, thalamus and brainstem. No systemic malignancies were found. The patient was suspected of having a diagnosis of nonvasculitic autoimmune inflammatory meningoencephalitis and treated with intravenous methylprednisolone pulse therapy. Her fever transiently dropped to within the normal range. However, she had a sudden seizure and a second MRI exhibited infiltrative lesions gradually extending throughout the whole brain. We performed a brain biopsy, and LC was histologically diagnosed. The patient received whole-brain radiation therapy, which diminished the fever and seizures. The patient died one year after the initial onset of fever.
The present case yields an important consideration that brain neoplasms, especially LC, cannot be ruled out, even in cases with clinical characteristics and examinations consistent with inflammatory diseases. Careful follow-up and histological study are vital for the correct diagnosis of LC.
Primary central nervous system malignant lymphoma (PCNSL) generally forms either a single or multiple isolated, solitary mass lesions in the brain parenchyma. A very rare PCNSL variant, known as lymphomatosis cerebri (LC), presents as the diffuse infiltration of lymphoma cells in gray and white matter without the formation of a cohesive tumor mass [1, 2]. In this study, we report the case of a patient with continuous fever and multiple brain lesions. Because the patient had autoantibodies with no positive findings of malignancy, she was initially suspected of having a diagnosis of nonvasculitic autoimmune inflammatory meningoencephalitis (NAIM). Because extensive immunotherapy failed to result in symptomatic improvements, we performed a brain biopsy, which revealed diffuse infiltration of lymphoma cells in the brain parenchyma. Thus, a diagnosis of LC was made. We showed that LC could follow a clinical course mimicking inflammatory disease and that careful attention was required to distinguish LC from inflammatory diseases.
A 66-year-old woman, who had been healthy with no relevant previous medical history, complained of continuous fever starting two months before initial presentation. She realized weakness on her left extremities and was admitted to a city hospital for evaluation of fever and left hemiparesis. Then, she was transferred to our hospital for further evaluation three weeks later. On examination, her general condition was normal, except for an elevated body temperature (38.0° Celsius). No lymph-nodes were palpable. Additionally, she did not complain of Sicca symptoms, night sweats or weight loss. The patient was alert and had normal cognitive function. She had left hemiparesis (grade 4 as measured by the Manual Muscle Strength Testing) with bilateral brisk deep tendon reflexes and extensor plantar responses. Sensory extinction was noted in her left extremities.
The blood sample tests showed a slightly elevated C-reactive protein level (0.68 mg/dl) and erythrocyte sedimentation rate (17 mm/h) as well as a high titer of antinuclear antibodies (x1280, speckled pattern). Anti-SS-A and anti-Ro52 antibodies were positive but anti-SS-B antibody was negative. Lip biopsy showed no inflammation. Immunoblotting revealed IgG-k monoclonal gammopathy; however, bone marrow histology showed 10 % proliferation of clonal plasma cells without light chain restriction, and Bence-Jones protein was not found. Tumor markers were negative and soluble interleukin-2 receptor (sIL-2R) was within the normal range. Cerebrospinal fluid (CSF) showed slight pleocytosis (11/μl; mature lymphocyte 94 %, no atypical cells). However, normal ranges of glucose and protein levels (73 mg/dl and 26 mg/dl, respectively) were observed. We also observed increments of both the IgG index (1.26) and interleukin 6 (29.4 pg/ml) but no increment of sIL-2R.
We tentatively diagnosed the patient as having NAIM associated with anti-SS-A and anti-Ro52 antibodies, as well as monoclonal gammopathy of undetermined significance. She was treated with intravenous methylprednisolone (mPSL) pulse therapy (1 g during the course of three days) and her fever transiently ceased. Three months after the onset of fever, she suddenly developed generalized tonic-clonic seizures (GTCS), which remained uncontrolled after the administration of antiepileptic medications. Intravenous immunoglobulin (IVIG) (0.4 g/kg in five days) had no beneficial effects. A second brain MRI showed extensive lesions that had developed in the bilateral frontotemporal lobes (Fig. 1e, f).
The patient had repeated GTCS, and accompanying severe aspiration pneumonia. She needed antibiotics and mechanical ventilator support. Considering the patient’s exhausted condition, we and her family chose to perform whole-brain radiation therapy (total 30 Gy) but not high-dose chemotherapy or rituximab therapy because the main adverse effect, bone marrow suppression, might be critical for her prognosis. Fever and seizures ceased for two months during and after the radiation therapy; however, she never regained consciousness. The follow-up MRIs revealed the progression of the lesions throughout the whole brain accompanying diffuse brain atrophy (Fig. 1g, h). She died one year after the initial onset of fever. No autopsy was permitted.
Unlike nodular lesions with contrast enhancement of PCNSL [3, 4], MRI findings of LC are generally consistent with diffuse leukoencephalopathy with absent or very faint patchy contrast enhancement, mimicking various white matter disorders [1, 2]. Therefore, diagnosing LC is a difficult challenge and cannot be accomplished using conventional MRI alone. Pathological examination is crucial for making an accurate diagnosis. Pathological examination should show diffuse infiltration of lymphoma cells in the parenchyma without resulting tissue destruction. Furthermore, lack of contrast enhancement in MRI and no destroyed vessels in the histopathological study are assumed to reflect an intact blood–brain barrier .
Previous reports of LC have shown several clinical features of this disease, such as subacute progressive dementia, personality changes, unsteady gait and epileptic seizures [5–7]: however, to the best of our knowledge, LC in patients with continuous fever has not been reported to date [3, 8].
In the present case, we first suspected NAIM based on findings that were suggestive of an inflammatory disease, such as the existence of autoantibodies with inflammatory CSF changes, multiple non-enhanced brain lesions on MRI and the transient improvement experienced after the initial mPSL treatment. NAIM is characterized as a steroid-responsive encephalopathy associated with nonspecific autoantibodies . In steroid-resistant cases of NAIM, the use of IVIG results in a sufficiently good outcome . In our case, however, the resistance to the subsequent immunotherapy led us to perform the brain biopsy, from which we were able to make a diagnosis of LC. A transient benefit from the mPSL may be explained by the reduction of the lymphocytotoxic effects.
Although there are no detectable lesions observed during the first experimental MRI, hyperperfusion lesions present in the basal ganglia, thalamus and brainstem, which were observed during the SPECT, might reflect infiltration of LC, indicating that the continuous fever may be explained by dysfunction of thermoregulation in the hypothalamus.
The prognosis of LC is generally considered to be poorer than that of PCNSL, and most LC patients are reported as dying within six months of the initial onset [5, 11]. In contrast, some recent LC cases diagnosed at early stages by pathological examination responded favorably to appropriate treatments [12, 13]. Therefore, early pathological diagnosis should be undertaken in patients suspected of having LC.
In patients with atypical presentations exhibiting features of NAIM, neoplastic disorders of the brain, especially LC, should be considered. Careful follow-up and timely tissue diagnosis are important to determine specific treatments and interventions.
CSF, cerebrospinal fluid; FLAIR, fluid-attenuated inversion recovery; GTCS, generalized tonic-clonic seizures; IVIG, intravenous immunoglobulin; LC, lymphomatosis cerebri; mPSL, methylprednisolone; MRI, magnetic resonance imaging; NAIM, nonvasculitic autoimmune inflammatory meningoencephalitis; PCNSL, primary central nervous system malignant lymphoma; sIL-2R, soluble interleukin-2 receptor; SPECT, single photon emission computed tomography
The authors wish to thank the Elsevier Language Editing for scientific English editing.
Dr. Murakami has received research funding from the Research Project Grant-in-aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology No. 26860675, 15H01563, the Takeda Science Foundation, the Kanae Foundation for the Promotion of Medical Science, the SENSHIN Medical Research Foundation. Dr. Hoshi was supported by grants from the Research Project Grant-in-aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology No. 26461314. Dr. Ugawa was supported by grants from the Research Project Grant-in-aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology No. 22390181, the Research Committee on Degenerative Ataxia from the Ministry of Health and Welfare of Japan, the Uehara Memorial Foundation and the Novartis Foundation (Japan) for the Promotion of Science.
Availability of data and material
TM: research project conception, organization, execution and writing of the first draft. KY, MS, AY, KN, MI, OS, YY, YT, YS, HI, KS, YH, AK and HT: research execution, manuscript review and critique. AH and YU: research project organization and execution, manuscript review and critique. All authors read and approved the final manuscript.
The authors declare that they have no competing interests.
Consent for publication
Written informed consent was obtained from the husband of the patient for publication of this case report and any accompanying images. A copy of the written consent is available for review by the editor of this journal.
Ethics approval and consent to participate
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
- Bakshi R, Mazziotta JC, Mischel PS, Jahan R, Seligson DB, Vinters HV. Lymphomatosis cerebri presenting as a rapidly progressive dementia: clinical, neuroimaging and pathologic findings. Dement Geriatr Cogn Disor. 1999;10(2):152–7.View ArticleGoogle Scholar
- Rollins KE, Kleinschmidt-DeMasters BK, Corboy JR, Damek DM, Filley CM. Lymphomatosis cerebri as a cause of white matter dementia. Human Pathol. 2005;36(3):282–90.View ArticleGoogle Scholar
- Gerstner ER, Batchelor TT. Primary central nervous system lymphoma. Arch Neurol. 2010;67(3):291–7.View ArticlePubMedGoogle Scholar
- Kuker W, Nagele T, Korfel A, Heckl S, Thiel E, Bamberg M, Weller M, Herrlinger U. Primary central nervous system lymphomas (PCNSL): MRI features at presentation in 100 patients. J Neurooncol. 2005;72(2):169–77.View ArticlePubMedGoogle Scholar
- Kitai R, Hashimoto N, Yamate K, Ikawa M, Yoneda M, Nakajima T, Arishima H, Takeuchi H, Sato K, Kikuta K. Lymphomatosis cerebri: clinical characteristics, neuroimaging, and pathological findings. Brain Tumor Pathol. 2012;29(1):47–53.View ArticlePubMedGoogle Scholar
- Raz E, Tinelli E, Antonelli M, Canevelli M, Fiorelli M, Bozzao L, Di Piero V, Caramia F. MRI findings in lymphomatosis cerebri: description of a case and revision of the literature. J Neuroimaging. 2011;21(2):e183–6.View ArticlePubMedGoogle Scholar
- Vital A, Sibon I. A 64-year-old woman with progressive dementia and leukoencephalopathy. Brain Pathol. 2007;17(1):117–8. 121.View ArticlePubMedGoogle Scholar
- Deutsch MB, Mendez MF. Neurocognitive features distinguishing primary central nervous system lymphoma from other possible causes of rapidly progressive dementia. Cogn Behav Neurol. 2015;28(1):1–10.View ArticlePubMedPubMed CentralGoogle Scholar
- Caselli RJ, Boeve BF, Scheithauer BW, O'Duffy JD, Hunder GG. Nonvasculitic autoimmune inflammatory meningoencephalitis (NAIM): a reversible form of encephalopathy. Neurology. 1999;53(7):1579–81.View ArticlePubMedGoogle Scholar
- Imperiale D, Guastamacchia G, Duca S, Appendino L, Marietti G, Romito A, Atzori C, Buffa C. Regression of white matter MRI abnormalities in nonvasculitic autoimmune inflammatory meningoencephalitis following intravenous immunoglobulin. Eur Neurol. 2007;57(4):244–5.View ArticlePubMedGoogle Scholar
- Courtois F, Gille M, Haven F, Hantson P. Lymphomatosis cerebri Presenting as a Recurrent Leukoencephalopathy. Case Rep Neurol. 2012;4(3):181–6.View ArticlePubMedPubMed CentralGoogle Scholar
- Watanabe M, Satoi H, Takahashi Y, Nishida N, Toda H, Matsumoto S. Remission of lymphomatosis cerebri induced by corticosteroid and high-doses intravenous methotrexate. Rinsho Shinkeigaku. 2012;52(7):486–90.View ArticlePubMedGoogle Scholar
- Samani A, Davagnanam I, Cockerell OC, Ramsay A, Patani R, Chataway J. Lymphomatosis cerebri: a treatable cause of rapidly progressive dementia. J Neurol Neurosurg Psychiatry. 2015;86(2):238–40.View ArticlePubMedGoogle Scholar